New £800-a-dose jab offers hope for diabetics suffering macular oedema

Brolucizumab treats fluid build-up in the eyes - called diabetic macular oedema - that can lead to blurred vision and, eventually, loss of sight.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news